Seed VC · UK
Hikma Ventures invests in digital health and life sciences companies where Hikma's expertise and global presence can accelerate revenue growth and enhance value creation. Focus areas include drug delivery, digital therapeutics, clinical trial innovation, respiratory, CNS, oncology, and chronic diseases.
Business models
saas_b2b, saas_b2c, platform, deeptech_ip, biotech_therapeutics
Customer segments
Enterprise, Healthcare Providers, Pharmaceutical Companies, Patients, Researchers
Geography
US, Europe, Global
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Hikma Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VCboom tracks Hikma Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Hikma Ventures is one of them — and we'll tell you exactly where they sit in your top 100.